Notably, in PD models, Nrf2 pathway activation has been shown to alleviate the accumulation of toxic α-synuclein, oxidative stress, and neuroinflammation, thereby reducing DAergic neuronal demise [22,23]. This evidence concerns the gene SNCA and Parkinson disease.